As of 2024-12-15, the EV/EBITDA ratio of Alliance Pharma PLC (APH.L) is 5.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. APH.L's latest enterprise value is 347.34 mil GBP. APH.L's TTM EBITDA according to its financial statements is 63.42 mil GBP. Dividing these 2 quantities gives us the above APH.L EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 4.9x - 5.9x | 5.2x |
| Forward P/E multiples | 5.3x - 6.8x | 6.0x |
| Fair Price | 41.20 - 63.47 | 49.93 |
| Upside | -14.5% - 31.7% | 3.6% |
| Date | EV/EBITDA |
| 2024-12-13 | 5.48 |
| 2024-12-12 | 5.48 |
| 2024-12-11 | 5.52 |
| 2024-12-10 | 5.59 |
| 2024-12-09 | 5.42 |
| 2024-12-06 | 5.30 |
| 2024-12-05 | 5.33 |
| 2024-12-04 | 5.37 |
| 2024-12-03 | 5.25 |
| 2024-12-02 | 5.24 |
| 2024-11-29 | 5.29 |
| 2024-11-28 | 5.26 |
| 2024-11-27 | 5.21 |
| 2024-11-26 | 5.21 |
| 2024-11-25 | 5.23 |
| 2024-11-22 | 5.25 |
| 2024-11-21 | 5.16 |
| 2024-11-20 | 5.14 |
| 2024-11-19 | 5.20 |
| 2024-11-18 | 5.29 |
| 2024-11-15 | 5.38 |
| 2024-11-14 | 5.35 |
| 2024-11-13 | 5.29 |
| 2024-11-12 | 5.34 |
| 2024-11-11 | 5.41 |
| 2024-11-08 | 5.37 |
| 2024-11-07 | 5.37 |
| 2024-11-06 | 5.43 |
| 2024-11-05 | 5.31 |
| 2024-11-04 | 5.20 |
| 2024-11-01 | 5.23 |
| 2024-10-31 | 5.18 |
| 2024-10-30 | 5.33 |
| 2024-10-29 | 5.02 |
| 2024-10-28 | 5.04 |
| 2024-10-25 | 5.22 |
| 2024-10-24 | 5.20 |
| 2024-10-23 | 5.24 |
| 2024-10-22 | 5.21 |
| 2024-10-21 | 5.17 |
| 2024-10-18 | 5.26 |
| 2024-10-17 | 5.26 |
| 2024-10-16 | 5.26 |
| 2024-10-15 | 5.30 |
| 2024-10-14 | 5.20 |
| 2024-10-11 | 5.21 |
| 2024-10-10 | 5.20 |
| 2024-10-09 | 5.08 |
| 2024-10-08 | 4.93 |
| 2024-10-07 | 4.98 |